Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0002148420-26-000006

Chief Commercial Officer acquired 140,766 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Berrios John Joseph · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-06 Grant or award : show line 1 in the form +140,766 140,766 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-06 Grant or award : show line 2 in the form Share option (right to buy) +174,612 174,612 D
Loading xslF345X06/form4-08072026_080836.xml…